Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Importin subunit alpha-7 (KPNA6) is a member of the karyopherin alpha family that functions as an adapter protein in the classical nuclear import pathway [1]. It recognizes and binds to proteins containing a nuclear localization signal (NLS) in the cytoplasm and forms a heterodimer with importin beta-1 to facilitate transport through the nuclear pore complex [1, 2]. KPNA6 is critically involved in the life cycle of several viruses; for instance, it is essential for the nuclear import of the Influenza A virus polymerase subunit PB2, which is a prerequisite for viral replication [2, 3]. Additionally, KPNA6 has been implicated in the pathogenesis of various cancers, including hepatocellular carcinoma and glioblastoma, where its overexpression promotes cell proliferation and migration by facilitating the nuclear entry of oncogenic factors [4, 5]. Therapeutic targeting of KPNA6 is being explored primarily through small molecules like ivermectin, which inhibits the importin alpha/beta-1 mediated transport of viral and cellular proteins [6, 7]. Sources: [1] UniProt (P52295); [2] Gabriel, G., et al. (2011) Nat Commun; [3] Wang, W., et al. (2017) J Virol; [4] Sun, J., et al. (2021) Front Oncol; [5] Geng, J., et al. (2021) J Exp Clin Cancer Res; [6] Caly, L., et al. (2020) Antiviral Res; [7] Jans, D. A., & Wagstaff, K. M. (2020) Biochem J.
Inhibition of the nuclear import of cargo proteins by disrupting the interaction between the importin alpha subunit and the nuclear localization signal (NLS) of the cargo or the importin beta-1 adapter.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Importin subunit alpha-7 (KPNA6) (KPNA6).